Loss of Nrdp1 Enhances ErbB2/ErbB3-Dependent Breast Tumor Cell Growth

Cancer Research - United States
doi 10.1158/0008-5472.can-06-2319
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

ErbB3 Downregulation Enhances Luminal Breast Tumor Response to Antiestrogens

Journal of Clinical Investigation
Medicine
2013English

An Insertion Mutation of ERBB2 Enhances Breast Cancer Cell Growth and Confers Resistance to Lapatinib Through AKT Signaling Pathway

Biology Open
BiochemistryAgriculturalGeneticsMolecular BiologyBiological Sciences
2020English

Nuclear ErbB2 Enhances Translation and Cell Growth by Activating Transcription of Ribosomal RNA Genes

Cancer Research
Cancer ResearchOncology
2011English

ErbB3-Dependent Motility and Intravasation in Breast Cancer Metastasis

Cancer Research
Cancer ResearchOncology
2006English

Functional Isolation of Activated and Unilaterally Phosphorylated Heterodimers of ERBB2 and ERBB3 as Scaffolds in Ligand-Dependent Signaling

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2012English

Oligomerization of the Nrdp1 E3 Ubiquitin Ligase Is Necessary for Efficient Autoubiquitination but Not ErbB3 Ubiquitination

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2014English

Nectin-Like Molecule-4/Cell Adhesion Molecule 4 Inhibits the Ligand-Induced Dimerization of ErbB3 With ErbB2

Scientific Reports
Multidisciplinary
2017English

Combining Lapatinib (GW572016), a Small Molecule Inhibitor of ErbB1 and ErbB2 Tyrosine Kinases, With Therapeutic Anti-ErbB2 Antibodies Enhances Apoptosis of ErbB2-overexpressing Breast Cancer Cells

Oncogene
Cancer ResearchGeneticsMolecular Biology
2005English

Antitumor Activity of a Novel Bispecific Antibody That Targets the ErbB2/ErbB3 Oncogenic Unit and Inhibits Heregulin-Induced Activation of ErbB3

Molecular Cancer Therapeutics
Cancer ResearchOncology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy